Sign up USA
Proactive Investors - Run By Investors For Investors

iAnthus Capital expected to have 'banner' year in 2018, reckons Canaccord

iAnthus provides financing and operating expertise to marijuana producers with operations in six US states
iAnthus Capital expected to have 'banner' year in 2018, reckons Canaccord
Pictured- a cannabis growing facility

iAnthus Capital Holdings Inc (CNSX:IAN) shares nudged 1% higher on Wednesday as it was reported broker Canaccord Genuity had the company as one of its top picks for 2018.

The Globe and Mail reports that analyst Matt Bottomley targets the shares at C$3.90 (they are currently C$3.34).

iAnthus provides financing and operating expertise to marijuana producers with operations in six US states.

"We continue to hold the view that 2018 will be a banner year for the company as its crown jewel assets in Massachusetts and New York are expected to make meaningful contributions by the back half of the year," said the analyst.

Key drivers include the recreational market in Massachusetts expected to start by mid-2018,  plans to enter the growing New York medical cannabis market via Citiva, and potential optionality in Florida.

"... we believe iAnthus is laying a strong foundation to gain a sizable East Coast presence heading into 2018," added the analyst.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full IAN profile View Profile

iAnthus Timeline

Related Articles

September 28 2018
HemoGenyx said it was pleased with the opportunities that had been unlocked for its CDX antibodies during the first half
cannabis plant
February 01 2018
Today, the group closed the US$18mln acquisition of Citiva Medical and Citiva USA

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use